The availability of abortion pills in states with bans on the procedure is under threat after Louisiana filed a lawsuit to curb mailing of the medication within its borders, claiming the process circumvents state law.
The lawsuit filed Monday accuses the Food and Drug Administration under then-president Joe Biden of lifting a requirement in 2023 that mifepristone be dispensed in person “for avowedly political reasons.” If not for the change, Louisiana says in its complaint, “activists in New York and California could not blanket pro-life states like Louisiana with mifepristone by mail.”
The lawsuit marks the latest attempt by conservative-led ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.